Sh Pharma announced that its subsidiary Changzhou Pharmaceutical Factory's Aiquapuerpae Alcoholamide tablets have been approved for production by the National Medical Products Administration. This pharmaceutical is suitable for adult and children 6 years and older with chronic immune thrombocytopenia who have a poor therapeutic response to glucocorticoids and immunoglobulins.
上海医药：艾曲泊帕乙醇胺片获批生产
Sh Pharma: Approval granted for production of Aprepitant Ethanolamine Tablets.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.